# HBsAg Seroclearance in Adults With HBV Related Liver Fibrosis After Receiving Combined Therapy of Peg-IFN and Tenofovir.

> **NCT04640129** · PHASE4 · UNKNOWN · sponsor: **Third Affiliated Hospital, Sun Yat-Sen University** · enrollment: 336 (estimated)

## Conditions studied

- Liver Fibrosis

## Interventions

- **DRUG:** PEG-Interferon Alfa, Tenofovir Disoproxil Fumarate
- **DRUG:** Tenofovir Disoproxil Fumarate

## Key facts

- **NCT ID:** NCT04640129
- **Lead sponsor:** Third Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-01
- **Primary completion:** 2025-11
- **Final completion:** 2025-11
- **Target enrollment:** 336 (ESTIMATED)
- **Last updated:** 2024-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04640129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04640129, "HBsAg Seroclearance in Adults With HBV Related Liver Fibrosis After Receiving Combined Therapy of Peg-IFN and Tenofovir.". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04640129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*